Moderna rises as CDC expands RSV vaccine guidance to include high-risk adults aged 50-59, boosting mResvia's reach.

A memo that purports to summarize a meeting held by members of a biotech trade group suggests deep concern about RFK Jr.’s ...

That whole meeting was a travesty,” says Fiona Havers, a physician and epidemiologist. After the ACIP firings, Havers ...

Moderna stock popped Wednesday after the CDC recommended the company's RSV vaccine for at-risk adults in their 50s.

Some members of the scientific community have concern that they’re coming out of the COVID pandemic—exposure to the virus, ...

The Trump administration’s new vaccine advisers endorsed this fall's flu vaccines late last week, but only those that don't ...

The newly appointed US Advisory Committee on Immunization Practices (ACIP) has announced two working groups that will review the US children’s vaccination schedule. Opening the first ACIP meeting ...

The high court sides with HHS on HIV PrEP drugs; Health Secretary RFK Jr.’s newly appointed CDC vaccine advisors discuss thimerosal in flu vaccines, skip vote on Moderna’s mRNA-based RSV vaccine; FDA ...

Merck's Winrevair gains FDA priority review for PAH label update after ZENITH trial shows major reduction in serious events and strong clinical impact.

Dr. Fiona Havers, who led the CDC’s tracking of hospitalizations from COVID-19 and RSV (respiratory syncytial virus), stepped down this week. "Unfortunately," she said in an email to colleagues ...